+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Treatment of active rheumatoid arthritis The effect on bone density and turnover



Treatment of active rheumatoid arthritis The effect on bone density and turnover



Arthritis & Rheumatism 42(9 SUPPL ): S127, Sept




(PDF emailed within 1 workday: $29.90)

Accession: 035980731

Download citation: RISBibTeXText


Related references

The study of bone mineral density and bone turnover markers in postmenopausal women with active rheumatoid arthritis. Modern Rheumatology 15(6): 410-414, 2006

A study of the link between bone turnover markers and bone mineral density with inflammation and body mass in postmenopausal women with active rheumatoid arthritis. Journal of Bone and Mineral Metabolism 31(2): 169-176, 2013

Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial. Osteoporosis International 17(5): 716-723, 2006

Serum osteocalcin as an index of bone turnover in active rheumatoid arthritis and in active psoriatic arthritis. Clinical Rheumatology 8(4): 494-498, 1989

Effect of weight bearing exercise training over bone mineral density, muscle strength and biochemical markers of bone turnover in patients with rheumatoid arthritis. Arthritis & Rheumatism 41(9 SUPPL ): S44, Sept, 1998

Effect of tumor necrosis factor alpha inhibition on bone density and turnover markers in patients with rheumatoid arthritis and spondyloarthropathy. Seminars in Arthritis and Rheumatism 39(2): 116-122, 2008

Denosumab Treatment Effects on Structural Damage, Bone Mineral Density, and Bone Turnover in Rheumatoid Arthritis: A Twelve-Month, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase II Clinical Trial. Yearbook of Medicine 2009: 12-13, 2009

Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial. Arthritis and Rheumatism 58(5): 1299-1309, 2008

Changes in bone mineral density (BMD) in patients with early, active rheumatoid arthritis (RA) after 1 year of treatment in the best study. 2006

Bone turnover in early rheumatoid arthritis. 2. Longitudinal bone density studies. Annals of the Rheumatic Diseases 44(9): 580-584, 1985

The effect of tocilizumab on bone mineral density in patients with methotrexate-resistant active rheumatoid arthritis. Rheumatology 53(5): 900-903, 2014

AB0313Short-Term Effects of Tnf Inhibitors on Bone Turnover Markers and Bone Mineral Density in Rheumatoid Arthritis:. Annals of the Rheumatic Diseases 75(Suppl 2): 1007.2-1008, 2016

Short-Term Effects of TNF Inhibitors on Bone Turnover Markers and Bone Mineral Density in Rheumatoid Arthritis. Calcified Tissue International 98(6): 580-585, 2017

Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, results from an exploratory, prospective study. Plos One 13(8): E0201527, 2018

AB0431The Effect of Tocilizumab on Bone Mineral Density in Patients with Methotrexate-Resistant Active Rheumatoid Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 950.1-950, 2014